-
RRBS data from TRACERx non-small cell lung cancer (NSCLC) tumours and matched normal adjacent tissue.
Study
EGAS00001006523
-
Multi-region RNA sequencing of tumour regions and tumour-adjacent normal lung tissue
Study
EGAS00001006517
-
Gene signature for predicting homologous recombination deficiency in triple-negative breast cancer
Study
EGAS00001006518
-
DERMATLAS__Tubular_adenoma
Study
EGAS00001006686
-
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
Study
EGAS00001004953
-
Characterization of MCSP+ melanoma DCC and MelDCC lines
Study
EGAS00001006702
-
The Precision Medicine in Liver Cancer across an Asia-pacific NETwork (PLANET) - Intratumoural immune heterogeneity
Study
EGAS00001003814
-
cfDNA in Hereditary And High-Risk Malignancies (CHARM)
Study
EGAS00001006539
-
Robust methylation-based classification of brain tumours using nanopore sequencing
Study
EGAS00001006540
-
The University of Hong Kong Colon Cancer GCV Study
Study
EGAS00001006707
-
Exome sequencing from cfDNA blood samples. 159 samples at 2x101bp Illumina reads in Fastq format.
Study
EGAS00001006656
-
GENOMIC MUTATION LANDSCAPE OF SKIN CANCERS FROM DNA REPAIR-DEFICIENT XERODERMA PIGMENTOSUM PATIENTS
Study
EGAS00001006732
-
Deciphering somatic mosaic structural variation in human blood lineages using single-cell multiomics
Study
EGAS00001006567
-
Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients
Study
EGAS00001006573
-
Uncovering tumor intrinsic and extrinsic factors that regulate hepatocellular carcinoma growth using patient derived xenograft assays
Study
EGAS00001004020
-
Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models: validation cohort
Study
EGAS00001006582
-
Human pan-cancer plasma cfRNA study - raw data
Study
EGAS00001006755
-
SDH_deficient_renal_tumours___WGS_
Study
EGAS00001004102
-
Genomic_characterisation_of_MGUS__
Study
EGAS00001004124
-
PDAC organoid genomic heterogeneity
Study
EGAS00001006782
-
The miR-185/PAK6 Axis Predicts Therapy Response and Regulates Survival of Drug-Resistant Leukemic Stem Cells in Chronic Myeloid Leukemia
Study
EGAS00001004153
-
The landscape of chromothripsis across adult cancer types
Study
EGAS00001004250
-
Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures
Study
EGAS00001006598
-
Integrative analysis of exome-seq, RNA-seq, ATAC-seq (bulk and single-cell), and Hi-C data generated from 3-D spatially mapped samples acquired during surgical resection from 10 patients diagnosed with IDH-WT glioblastoma
Study
EGAS00001006785
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations - WGS data
Study
EGAS00001006610
-
Hi-C analysis of metastatic prostate tumors - Part 2
Study
EGAS00001006612
-
Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures (Hipo_021)
Study
EGAS00001006629
-
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways
Study
EGAS00001006631
-
Neoantigen Peptides derived from V(D)J-recombined Immunoglobulins Drive Outgrowth of Cytolytic CD8+ T-cells
Study
EGAS00001008229
-
Persistent Mutation Burden Drives Sustained Anti-Tumor Immune Responses
Study
EGAS00001006660
-
Identification of neoantigen from MSI-CRC patient derived organoids and its application for targeting by autologous T cells
Study
EGAS00001006633
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations - Cancer Panel data
Study
EGAS00001006642
-
Whole genome analysis of pediatric patients with medulloblastoma
Study
EGAS00001006653
-
DNA methylation landscape of prostate cancer
Study
EGAS00001006670
-
Recurrent DNMT3B gene rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL
Study
EGAS00001007383
-
Genomic Study of Gastric Cancer
Study
EGAS00001005032
-
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation
Study
EGAS00001006678
-
Identification of genomic aberrations in low-grade serous ovarian cancer
Study
EGAS00001006679
-
DERMATLAS__Tubular_adenoma_RNAseq
Study
EGAS00001006685
-
The molecular landscape of homologous recombination deficient, end-stage, high grade serous ovarian cancer
Study
EGAS00001006789
-
Single-cell roadmap of immune cell responses in chronic myeloid leukemia
Study
EGAS00001005044
-
Pre-neoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma
Study
EGAS00001006692
-
Tissue DNA, WBC DNA and cfDNA (deep-)sequencing of mCRC patients treated with doublet chemotherapy and anti-EGFR in the CAIRO5 study
Study
EGAS00001006695
-
Discovery of cancer prognostic markers based on comparison of gene expression in colorectal cancer samples.
Study
EGAS00001005068
-
Characterization of chromatin accessibility in metastatic prostate cancer
Study
EGAS00001006698
-
Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer
Study
EGAS00001005071
-
single-stranded DNA study
Study
EGAS00001005093
-
Structural Expression of BMMF in tissues of colorectal, lung and pancreatic cancer patients
Study
EGAS00001006744
-
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling (hipo_021)
Study
EGAS00001006747
-
Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in ICI-related pneumonitis
Study
EGAS00001006762